Versant Venture Capital Iii, L.p. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of PhaseRx Inc (PZRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseRx Inc (PZRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseRx Inc (PZRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Iii, L.p. made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .

In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Iii, L.p. made no insider transaction in OpGen Inc (OPGN). Other recent insider transactions involving OpGen Inc (OPGN) include a net purchase of 2,845,603 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of OpGen Inc (OPGN) in total and bought 5,245,603 shares, with a net purchase of 5,245,603 shares. During the past 18 months, 2,400,000 shares of OpGen Inc (OPGN) were sold and 5,245,603 shares were bought by its insiders, resulting in a net purchase of 2,845,603 shares.

OpGen Inc (OPGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Iii, L.p. made no insider transaction in Veracyte Inc (VCYT). Other recent insider transactions involving Veracyte Inc (VCYT) include a net sale of 131,749 shares made by Evan/ Fa Jones , a net sale of 12,841 shares made by Muna Bhanji , and a net sale of 13,870 shares made by Karin Eastham .

In summary, during the past 3 months, insiders sold 10,652 shares of Veracyte Inc (VCYT) in total and bought 0 shares, with a net sale of 10,652 shares. During the past 18 months, 195,216 shares of Veracyte Inc (VCYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 195,216 shares.

Veracyte Inc (VCYT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Venture Capital Iii, L.p. made no insider transaction in Skye Bioscience Inc (SKYE). Other recent insider transactions involving Skye Bioscience Inc (SKYE) include a net purchase of 5,389,737 shares made by 5am Partners Vii, Llc , a net purchase of 1,762,000 shares made by Punit Dhillon , and a net sale of 266,337 shares made by Andrew J. Schwab .

In summary, during the past 3 months, insiders sold 532,674 shares of Skye Bioscience Inc (SKYE) in total and bought 0 shares, with a net sale of 532,674 shares. During the past 18 months, 532,674 shares of Skye Bioscience Inc (SKYE) were sold and 5,663,122 shares were bought by its insiders, resulting in a net purchase of 5,130,448 shares.

Skye Bioscience Inc (SKYE)'s detailed insider trading history can be found in Insider Trading Tracker table.